| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 2,222,435 | 1,311,679 | 1,250,108 | 1,213,816 |
| Short-term investments | 0 | 248,930 | 227,731 | 218,309 |
| Accounts receivable, net | 903,914 | 908,214 | 790,266 | 855,855 |
| Inventory | 1,273,221 | 1,298,883 | 1,382,173 | 1,340,169 |
| Other current assets | 205,500 | 185,784 | 204,265 | 177,183 |
| Total current assets | 4,605,070 | 3,953,490 | 3,854,543 | 3,805,332 |
| Long-term investments | 0 | 492,242 | 512,937 | 508,592 |
| Property, plant and equipment, net | 958,071 | 952,508 | 1,038,187 | 1,030,385 |
| Intangible assets, net | 204,662 | 213,837 | 233,112 | 239,620 |
| Goodwill | 196,199 | 196,199 | 196,199 | 196,199 |
| Deferred tax assets | 1,500,598 | 1,508,697 | 1,509,109 | 1,427,021 |
| Restricted cash equivalents | 850,000 | NaN | NaN | NaN |
| Other assets | 276,416 | 277,049 | 270,781 | 249,192 |
| Total assets | 8,591,016 | 7,594,022 | 7,614,868 | 7,456,341 |
| Accounts payable and accrued liabilities | 793,152 | 759,031 | 798,438 | 684,247 |
| Total current liabilities | 793,152 | 759,031 | 798,438 | 684,247 |
| Long-term convertible debt, net | NaN | 597,176 | 596,663 | 596,162 |
| Long-term debt, net | 1,430,282 | NaN | NaN | NaN |
| Other long-term liabilities | 155,475 | 150,816 | 163,056 | 148,819 |
| Total liabilities | 2,378,909 | 1,507,023 | 1,558,157 | 1,429,228 |
| Common stock, 0.001 par value 500,000,000 shares authorized 193,268,870 and 192,300,101 shares issued and outstanding, respectively | 193 | 192 | 192 | 192 |
| Additional paid-in capital | 5,966,868 | 5,956,582 | 5,900,968 | 5,851,637 |
| Company common stock held by the nonqualified deferred compensation plan | 10,450 | 10,508 | 11,291 | 11,674 |
| Accumulated other comprehensive loss | -4,237 | -13,473 | -33,937 | -44,565 |
| Retained earnings | 259,733 | 154,206 | 200,779 | 231,523 |
| Total stockholders equity | 6,212,107 | 6,086,999 | 6,056,711 | 6,027,113 |
| Total liabilities and stockholders equity | 8,591,016 | 7,594,022 | 7,614,868 | 7,456,341 |
BIOMARIN PHARMACEUTICAL INC (BMRN)
BIOMARIN PHARMACEUTICAL INC (BMRN)